SCHEMBL8316367

SCHEMBL8316367

COc1ccccc1/C=C\c1nc2c(s1)NCCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.41
PTGS1 P23219 3/20 0.41
NFE2L2 Q16236 4/20 0.40
TRPA1 O75762 1/20 0.40
ALOX5 P09917 1/20 0.38
CYP1A2 P05177 5/20 0.37
CYP1A1 P04798 4/20 0.37
CYP1B1 Q16678 4/20 0.37
ABL1 P00519 1/20 0.37
LCK P06239 1/20 0.37
LYN P07948 1/20 0.37
SRC P12931 1/20 0.37
CSK P41240 1/20 0.37
BTK Q06187 1/20 0.37
PTK6 Q13882 1/20 0.37
CYP19A1 P11511 1/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8316370 1.00 PTGS2 (0.41) PTGS2PTGS1NFE2L2TRPA1ALOX5
SCHEMBL8316364 1.00 PTGS2 (0.41) PTGS2PTGS1NFE2L2TRPA1ALOX5
Oxalic Acid SCHEMBL8315183 0.94 PTGS2 (0.39) PTGS2PTGS1NFE2L2TRPA1ALOX5
Oxalic Acid SCHEMBL8315178 0.94 PTGS2 (0.39) PTGS2PTGS1NFE2L2TRPA1ALOX5
SCHEMBL8311619 0.90 MAPT (0.44) NFE2L2CYP1A2CYP1A1CYP1B1CYP19A1
SCHEMBL8311200 0.90 MAPT (0.44) NFE2L2CYP1A2CYP1A1CYP1B1CYP19A1
SCHEMBL8313159 0.86 MAPT (0.45) NFE2L2CYP1A2CYP1A1CYP1B1CYP19A1
SCHEMBL8313155 0.86 MAPT (0.45) NFE2L2CYP1A2CYP1A1CYP1B1CYP19A1
SCHEMBL8317000 0.85 CYP1A1 (0.44) NFE2L2CYP1A2CYP1A1CYP1B1CYP19A1
SCHEMBL8316999 0.85 CYP1A1 (0.44) NFE2L2CYP1A2CYP1A1CYP1B1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0351856-B1 Thiazolo[5,4-b]azepine compounds TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1999-09-15 EP disclosed
US-5300639-A 2-oxo-3-carbonylamino-substituted azepine intermediates; lipoperoxide formation inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-04-05 US disclosed
US-5118806-A Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-02 US disclosed
US-4956360-A LIPOPEROXIDE INHIBITORS, ENZYME INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-09-11 US disclosed